The Society of the Four Arts is collaborating with the Garden Club of Palm Beach for a lecture featuring botanical genetic ...

Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...

Is REGN a good stock to buy? We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Ocular Capital’s Substack. In this article, we will summarize the bulls’ thesis on REGN. Regeneron ...

Things are changing fast, and a lot of that has to do with new medical technology. As we head into 2026, some really interesting developments are popping up that could change how we do things. We’re ...